Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
HHL | What dos this merger mean for shareholders? | 14/06/17 | 1 | 2.0K | |||
|
|||||||
HHL | Ann: Corporate Governance Statement | 02/06/17 | 0 | 784 | |||
|
|||||||
HHL | Ann: Ceasing to be a substantial holder for BSE | 02/06/17 | 0 | 762 | |||
|
|||||||
HHL | Ann: Change of Director's Interest Notice | 02/06/17 | 0 | 836 | |||
|
|||||||
HHL | Ann: Change in substantial shareholding from BKW | 02/06/17 | 0 | 770 | |||
|
|||||||
HHL | Ann: Change in substantial holding from SOL | 02/06/17 | 0 | 853 | |||
|
|||||||
HHL | News: HHL Hunter Hall International says merger with Pengana Capital approved by HHL shareholders | 01/06/17 | 0 | 753 | |||
|
|||||||
HHL | Ann: Becoming a substantial holder | 01/06/17 | 0 | 787 | |||
|
See All Discussions